Synens

Illzach, France Founded: 2019 • Age: 7 yrs
Provider of drug abuse detection devices
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About Synens

Synens is a company based in Illzach (France) founded in 2019 by Leonard Dumea. Synens operates in a competitive market with competitors including Pocket Naloxone, Celero Systems, NIRLAB, Labb and ION-GAS, among others.

  • Headquarter Illzach, France
  • Founders Leonard Dumea
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Synens

Premium access

Detailed funding history for Synens

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Synens

Investments
Premium access

Investment portfolio details for Synens

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Synens

Premium access

Detailed financials for Synens

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Synens Comparisons

Synens Primary company
Description
Provider of drug abuse detection devices
Location
Illzach, France
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Synens

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Synens

Synens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pocket Naloxone, Celero Systems, NIRLAB, Labb and ION-GAS, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
FDA-approved devices for opioid overdose management are developed.
Locked Locked Locked
An ingestible device for detecting opioid overdoses is developed.
Locked Locked Locked
Offers handheld devices for instant material composition analysis using spectroscopy.
Locked Locked Locked
Mobile app for efficient drug testing and rapid results via various specimen types.
Locked Locked Locked
Develops customized analytical devices for medical, forensic, and quality assurance applications.
Premium access

Detailed competitors of Synens

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Synens

Premium access

Complete news archive for Synens

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Synens

Synens was founded in 2019.

Synens is headquartered in Illzach, France. It is registered at Illzach, Grand Est, France.

Leonard Dumea is the current CEO of Synens. They have also founded this company.

Synens was founded in 2019 and is based in Illzach, France. Drug abuse detection devices are developed and supplied within the medical diagnostics sector. Operations focus on point-of-care testing solutions, including the OM90 oral fluid drug test kit for on-site sample analysis and the D1 Handheld Analyzer for identifying multiple drugs and compounds. These tools support detection efforts in various settings.

Synens's top competitors include Pocket Naloxone, Celero Systems and NIRLAB.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available